Zu Hauptinhalt springen

Overview


In the first funding period (2019 to 2022) of the Collaborative Research Centre 1350, researchers from basic science fields and clinical disciplines at Universit?t Regensburg and Friedrich-Alexander-Universit?t Erlangen-Nürnberg joined forces to study the tubulointerstitium. In the present funding period (2023 to 2026), the successful research of CRC 1350 is continued as Transregio TRR 374 - funded by the German Research Foundation (DFG).

??????

Spokesperson
Prof. Dr. Mario Schiffer
Medizinische Klinik 4 - Nephrologie und Hypertensiologie
Ulmenweg 18
D-91054 Erlangen

Tel.: ++49 9131/85 390